Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
The Long Run with Luke Timmerman
00:00
Naming the company 'Candid'
Ken explains the origin of the name and his commitment to transparency with investors and teams.
Play episode from 56:05
Transcript
